The AMF Enforcement Committee fined a Dutch trading firm and three Dutch traders for price manipulation on French markets, demonstrating the regulator's cross-border enforcement reach against market abuse. This case underscores AMF's aggressive stance on manipulative trading practices, serving as a deterrent for international firms and individuals active in EU-linked markets. Compliance teams should note it as evidence of heightened scrutiny on trading desks handling correlated instruments.
What Changed
This is an enforcement action, not a regulatory change; it reinforces existing prohibitions under the Market Abuse Regulation (MAR, Regulation (EU) No 596/2014) against price manipulation, including fixing prices at abnormal or artificial levels through deceptive trades. It aligns with prior AMF decisions, such as the €20 million fine on Morgan Stanley for similar OAT/OLO manipulations via futures positioning (decision dated 4 December 2019).
Suggested Considerations
- Enhance surveillance: Implement real-time monitoring for manipulative patterns, such as aggressive positioning in futures to influence cash bonds or closing prices (e.g., lowering prices via late-session sales).
- Trader training: Mandatory annual programs on MAR prohibitions, emphasizing cross-instrument correlations and "artificial level" tests; document inconsistencies with desk strategies.
- Internal controls: Review and audit trading strategies for deception risks; ensure post-trade analysis flags abnormal volume/price impacts.
- Reporting: Strengthen breach reporting under AMF procedures (Articles 145-1 to 145-4); prepare for cross-border cooperation.
- Compliance reviews: Conduct gap analyses against AMF Enforcement Committee rationales in similar cases (e.g., EcoR1 IPO manipulation).
Compliance Impact
Urgency: High – This signals AMF's expanding cross-jurisdictional enforcement (Dutch firm/traders), with fines on firms and individuals, amid proposed powers enhancements (e.g., penalty payments, communication on probes). Firms face personal accountability risks and market reputation damage; non-EU entities cannot assume immunity if impacting French markets. Immediate surveillance upgrades are essential pre-30 June 2026 MAR-aligned rules.